DENYES NANCY

Track

Insider profile

DENYES NANCY's trades of aTyr Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
406.01
Quantity 74,446 +2.0%
Value US$1,297,114
Transaction date
Sale
Price
323.97
Quantity 4,899 +13.1%
Value US$2,531,171
Transaction date
Sale
Price
324.21
Quantity 79,616 +44.6%
Value US$2,973,546
Transaction date
Purchase
Price
1.86
Quantity 5,000 +29.0%
Value US$9,276
Transaction date
Planned sale
Price
3.62
Quantity 322 -10.5%
Value US$1,166
Transaction date
Planned sale
Price
0.45
Quantity 4,651 -15.5%
Value US$2,093
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-04 2026-02-04
S Sale
74,446 +2.0%
406.01
US$1,297,114 		74,446 +2.0% 406.01 US$1,297,114
2026-02-04 2026-02-04
S Sale
4,899 +13.1%
323.97
US$2,531,171 		4,899 +13.1% 323.97 US$2,531,171
2025-02-04 2025-02-04
S Sale
79,616 +44.6%
324.21
US$2,973,546 		79,616 +44.6% 324.21 US$2,973,546
2024-06-06 2024-06-05
B Purchase
5,000 +29.0%
1.86
US$9,276 		5,000 +29.0% 1.86 US$9,276
2020-05-28 2020-05-20
PlS Planned sale
322 -10.5%
3.62
US$1,166 		322 -10.5% 3.62 US$1,166
2019-05-20 2019-05-17
PlS Planned sale
4,651 -15.5%
0.45
US$2,093 		4,651 -15.5% 0.45 US$2,093